Developing a first-in-class, 3rd generation Polo-like Kinase 1 (PLK1) Inhibitor to treat leukemias, lymphomas and solid tumor cancers
Trovagene has the committees listed below in place. The grid below provides an overview of the individuals that make up each committee. To learn more about a particular committee or an individual member click the titles below.
Executive Compensation Committee
Corporate Governance and Nominating Committee